Extended Injection Intervals After Switching From Ranibizumab to Aflibercept in Macular Edema Due to Central Retinal Vein Occlusion

Journal of Ophthalmology - Egypt
doi 10.1155/2018/8656495
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Hindawi Limited

Related search

Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Intravitreal Triamcinolone Acetonide Injection for Macular Edema Due to Central Retinal Vein Occlusion Persisting Despite Multiple Intravitreal Bevacizumab Injections

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2014English

Intravitreal Steroids Versus Observation for Macular Edema Secondary to Central Retinal Vein Occlusion

2009English

Intravitreal PRN Ranibizumab Treatment for Macular Edemadue to Branch Retinal Vein Occlusion

Turkish Journal of Medical Sciences
Medicine
2017English

Intravitreal Dexamethasone Implant (Ozurdex) for Macular Edema Secondary to Retinal Vein Occlusion

International Journal of Research Studies in Medical and Health Sciences
2017English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Initial Treatment of Macular Oedema Due to Central Retinal Vein Occlusion—which Anti-Vegf Agent to Choose?

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2019English

Unilateral Macular Edema With Central Retinal Vein Occlusion in Systemic Lupus Erythematosus: A Case Report

Clinical Ophthalmology
Ophthalmology
2013English

Comparison of the Efficacy and Safety of Drug Therapies for Macular Edema Secondary to Central Retinal Vein Occlusion

BMJ Open
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy